|
![]() • Assadi AH, Zhang G, Beffert U, McNeil RS, Renfro AL, Niu S, Quattrochi CC, Antalffy BA, Sheldon M, Wynshaw-BorisA, Armstrong DD, Herz J, D'Arcangelo G, Clark GD. Interaction of reelin signaling and Lis1 in brain development. Nature Genetics. 2003 Oct 26 [Epub ahead of print]. • Sutton VR, O'Brien WE, Clark GD, Kim J, Wanders RJ. 3-Hydroxy-2-methylbutyryl CoA dehydrogenase deficiency. J Inherit Metab Dis. 2003;26(1):69-71. • Yan W, Assadi AH, Wynshaw-Boris A, Eichele G, Matzuk MM, Clark GD. Previously uncharacterized roles of platelet-activating factor acetylhydrolase 1b complex in mouse spermatogenesis. Proc Natl Acad Sci USA. 2003 Jun 10;100(12):7189-94. • Clark GD. Brain development and the genetics of brain development. Neurol Clin. 2002 Nov;20(4):917-39. • Poolos NP, Das S, Clark GD, Lardizabal D, Noebels JL, Wyllie E, Dobyns WB. Males with epilepsy, complete subcortical band heterotopia, and somatic mosaicism for DCX. Neurology. 2002 May 28;58(10):1559-62. • Clark GD. Cerebral gyral dysplasias: molecular genetics and cell biology. Curr Opin Neurol. 2001 Apr;14(2):157-62. • Clark GD, Zorumski CF, McNeil RS, Happel LT, Ovella T, McGuire S, Bix GJ, Swann JW. Neuronal platelet-activating factor receptor signal transduction involves a pertussis toxin-sensitive G-protein. Neurochem Res. 2000 May;25(5):603-11. • Sweeney KJ, Clark GD, Prokscha A, Dobyns WB,
Eichele G. Lissencephaly associated mutations suggest a
requirement for the PAFAH1B heterotrimeric complex in brain
development. • Clark GD, Noebels JL.: Cortin disaster: lissencephaly genes spell double trouble for the developing brain. Ann Neurol 45(2):141-2, 1999. • Clark, G.D., Swann, J.W. and Miller, G.: From molecule to tissue: normal and abnormal brain development. In The Cerebral Palsies: Causes, Consequences, and Management. Butterworth-Heinemann, Newton, MA. 1998. • Hirotsune, S., Fleck, M.W., Gambello, M.J., Bix, G.J., Chen, A., Clark, G.D., Ledbetter, D.H., McBain, C.J. and Wynshaw-Boris, A.: Graded reduction of pafah B Lis1gene activity results in neuronal cell autonomous migration defects and early embryonic lethality. Nature Genetics 19(4):333-9, 1998. • Bix, G.J. and Clark, G.D.: Platelet-activating factor receptor stimulation disrupts neuronal migration in vitro. Journal of Neuroscience 18:307-318, 1998. • Bix, G.J. and Clark, G.D.: Elvax as a slow-release delivery agent for a platelet-activating factor receptor agonist and antagonist. J. Neuroscience Methods 77:67-74, 1997. • Clark, G.D., Mizuguchi, M., Antalffy, B. Barnes, J. and Armstrong, D.: Predominat localization of the LIS family of gene products to Cajal-Retzius cells and ventricular neuroepithelium in the developing human cortex. J. of Neuropathology and Experimental Neurology 56(9): 1044-1052, 1997. • Clark, G.D. and Fishman, M.A. The role of migrational disorders in epilepsy. Current Neurology, ed. Stanley Appel 17:237-264, 1997. • Clark, G.D., McNeil, R.S., Bix, G.T., and Swann, J.W. Platelet-activating factor produces neuronal growth cone collapse. Neuroreport, 6:2569-2575, 1995. • Clark, G.D., Happel, L.T., Zorumski, C.F., and Bazan, N.G. The role of platelet- activating factor in the release of excitotoxic neurotransmitters. J. Lipid Mediators & Cell Signalling, 10:95-98, 1994. • Kato, K., Clark, G.D., Bazan, N.G., and Zorumski, C.F. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature, 367:175-179, 1994. • Bazan, N. Zorumski, C., and Clark, G. The activation of phospholipase A2 and release of arachidonic acid and other lipid mediators at the synapse: the role of platelet-activating factor. J. Lipid Mediators, 6:421-427, 1993. • Clark, G., Happel, L., Zorumski, C., and Bazan, N. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron, 9:1211-1216, 1992. • Zorumski CF, Thio LL, Clark GD, Clifford DB. Blockade of desensitization augments quisqualate excitotoxicity in hippocampal neurons. Neuron. 1990 Jul;5(1):61-6. • Clark GD, Clifford DB, Zorumski CF. The effect of agonist concentration, membrane voltage and calcium on N-methyl-D-aspartate receptor desensitization. Neuroscience. 1990;39(3):787-97. |
BCM Home BCM Intranet Privacy Notices Contact BCM BCM Site Map
(c)1998-2006 Baylor College of
Medicine
Cain Foundation Pediatric Neurology Research
Foundation Laboratories
Feigin Center, Suite 955, Texas Children's Hospital
1102 Bates Avenue, MC 3-6365
Houston, TX 77030
Phone: 832-824-3968 | Fax:
832-825-4217
E-mail:
Cain_Found@bcm.tmc.edu
Last Modified: February 9, 2006